Literature DB >> 12500456

Primary and secondary allergies to laboratory animals.

Leslie E Goodno1, Gregg M Stave.   

Abstract

Although laboratory animal allergy (LAA) is a significant occupational hazard among workers exposed to laboratory animals, few studies have evaluated long-term risks to workers who remain in the workplace. This short-term focus has obscured the evaluation of subsequent animal allergies (secondary LAA). We analyzed surveillance data from a 10-year LAA prevention program to estimate incidence rates of primary and secondary LAA and to evaluate the effectiveness of the prevention program in reducing the development of primary LAA. The 10-year incidence rates of primary and secondary LAA were 1.34 (95% CI, 0.78-1.90) and 11 (95% CI, 7.4-14.6) cases per 100 person-years, respectively. The annual incidence of primary LAA was reduced from 3.6% to 0 in the first 5 years and did not rise above 1.2% over the remaining years, whereas the incidence of secondary LAA was greater than 8% in most years. These findings suggest that programs effective at preventing primary LAA may need to be evaluated for their effectiveness at protecting against further risk.

Entities:  

Mesh:

Year:  2002        PMID: 12500456     DOI: 10.1097/00043764-200212000-00008

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  3 in total

1.  Incidence of allergy and allergy symptoms among workers exposed to laboratory animals.

Authors:  L Elliott; D Heederik; S Marshall; D Peden; D Loomis
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

Review 2.  Occupational Animal Allergy.

Authors:  Gregg M Stave
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

3.  Laboratory animals and respiratory allergies: the prevalence of allergies among laboratory animal workers and the need for prophylaxis.

Authors:  Erica Ferraz; Luisa Karla de Paula Arruda; Ericson Bagatin; Edson Z Martinez; Andrea A Cetlin; Christian S Simoneti; Amanda S Freitas; José A B Martinez; Marcos C Borges; Elcio O Vianna
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.